Stock

Strategic Chaos or Tactical Goldmine? What QQQ’s Chart is Whispering Right Now

June 5, 2025
Stock

Why ADX Can Mislead You — And How to Avoid It

June 5, 2025
Stock

S&P 500 on the Verge of 6,000: What’s at Stake?

June 5, 2025
Investing

Scoping Study Demonstrates Low Cost ISR Uranium Potential

June 5, 2025
Investing

Satellite Imagery and Gold Exploration

June 5, 2025
Investing

Finlay Minerals Announces Increase in Size of Non-Brokered Private Placement of Flow-Through Shares and Non-Flow-Through Units

June 5, 2025
Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

You may also like

Crypto Market Recap: Swiss Central Bank Dismisses Bitcoin...

April 26, 2025

Manindi Ti-V-Fe Discovery Delivers High-Grade Concentrates

May 16, 2025

McDermitt Project Fast-Tracked Under U.S. FAST-41 Initiative

April 22, 2025

Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy...

May 15, 2025

Multiple New Multi-Commodity Targets

May 12, 2025

ARR advances permitting at Cowboy State Mine

May 28, 2025

Initial Exploration Program Completed at Cosmo Gold Project

April 29, 2025

Uranium Stocks: 5 Biggest Companies in 2025

May 20, 2025

Finlay Minerals Receives TSX Venture Exchange Approval for...

May 3, 2025

Top 5 Canadian Mining Stocks This Week: Lion...

May 3, 2025